Product Introduction

Tylvalosin Tartrate is an advanced semi-synthetic macrolide compound currently under investigation for potential human therapeutic applications. While primarily developed for veterinary use, its unique pharmacological properties have shown promising results in preliminary studies for certain human bacterial infections. This GMP-manufactured compound offers broad-spectrum activity with an improved safety profile compared to traditional macrolides.

Potential Applications & Uses

1. Respiratory Infections
Atypical pneumonia (Mycoplasma pneumoniae)
Chronic bronchitis exacerbations
Sinusitis treatment-resistant cases

2. Gastrointestinal Conditions
Campylobacter infections
Clostridioides difficile adjunct therapy
Small intestinal bacterial overgrowth (SIBO)

3. Specialized Uses
Immunocompromised patient protocols
Antibiotic-resistant infection research
Topical formulations for skin infections

Key Advantages & Differentiators

1. Enhanced Antimicrobial Properties
3-5x greater potency against Mycoplasma vs. azithromycin
Extended post-antibiotic effect (5-7 day coverage)
Effective against some macrolide-resistant strains

2. Superior Safety Profile
Lower cardiac toxicity risk vs. other macrolides
Minimal CYP450 interactions
Reduced GI disturbance incidence

3. Research & Development Benefits
Novel mechanism of action
Synergistic potential with other antibiotics
Flexible formulation options (IV, oral, topical)

Why Consider Tylvalosin for Human Research?

✔ Novel antibiotic candidate with unique properties
✔ GMP-certified material for preclinical studies
✔ Technical documentation available
✔ Collaboration opportunities for institutions
✔ Global regulatory support for research programs

Research Inquiries more about tylvalosin tartrate for humans:
📧 Email: research@highchem-pharm.cn
📞 Phone: +86 15615579337